Exploring What Is the New Drug for Stroke Patients?: Tenecteplase and Future Innovations
•
4 min read
In March 2025, the U.S. Food and Drug Administration (FDA) approved Tenecteplase (TNKase) for acute ischemic stroke, marking the first new thrombolytic drug approval for this condition in nearly 30 years. This significant development directly addresses the key question: **What is the new drug for stroke patients?** It offers a faster, more streamlined approach to dissolving blood clots and is already changing clinical practice.
